Healthcare -
Biotechnology - NASDAQ - US
$ 6.16
-0.324 %
$ 276 M
Market Cap
-11.41
P/E
YMAB - ACCOUNTS PAYABLE
Accounts Payable YMAB - Y-mAbs Therapeutics, Inc.
6.06 M
LAST VALUE
-33.13%
2 YEAR CAGR
0.63%
5 YEAR CAGR
0.00%
10 YEAR CAGR